What is the most recent FDA action on file for O&M HALYARD INC?

June 3, 2026. Argus HQ ingests new FDA enforcement records daily.

Has O&M HALYARD INC had product recalls?

Yes, 1 recall on file. See the full history below for each one.

Is this FDA enforcement data for O&M HALYARD INC official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has O&M HALYARD INC had?

Argus HQ has recorded 1 FDA events for O&M HALYARD INC: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

O&M HALYARD INC — FDA Enforcement History

FDA action counts

Total FDA actions	1
Warning letters	0
Recalls	1
Approval records	0
Form 483 inspection citations	0
Most recent action	June 3, 2026

Key takeaway: Argus HQ has recorded 1 FDA events for O&M HALYARD INC: 0 warning letters, 1 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-06-03 to 2026-06-03. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. O&M HALYARD INC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-06-03, Argus HQ recorded an FDA recall for O&M HALYARD INC, rated "high" severity in Argus HQ's classification: O&M HALYARD INC — Class II recall: Halyard Purezero Ultraviolet Nitrile Exam Gloves Reference Numbers: 48771 (XS),…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action on file for O&M HALYARD INC?: June 3, 2026. Argus HQ ingests new FDA enforcement records daily.
Has O&M HALYARD INC had product recalls?: Yes, 1 recall on file. See the full history below for each one.
Is this FDA enforcement data for O&M HALYARD INC official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has O&M HALYARD INC had?: Argus HQ has recorded 1 FDA events for O&M HALYARD INC: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

O&M HALYARD INC — Class II recall: Halyard Purezero Ultraviolet Nitrile Exam Gloves Reference Numbers: 48771 (XS),… →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). O&M HALYARD INC — FDA Enforcement History. Digital Empire LLC. Retrieved from https://argushq.ai/company/o-and-m-halyard-inc

MLA

"O&M HALYARD INC — FDA Enforcement History." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/o-and-m-halyard-inc.

Chicago

Argus HQ Research. "O&M HALYARD INC — FDA Enforcement History." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/o-and-m-halyard-inc.

BibTeX

@misc{argushq_argushq_ai_company_o_and_m_halyard_inc_2026,
  title = {O&M HALYARD INC — FDA Enforcement History},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/o-and-m-halyard-inc},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗